Skip to contentScholarGate
LibraryBookshelfDeskReview StudioAssistant
Sign in
On this page
IntuitionHow it worksWhen to use itStrengths & limitationsCommon pitfallsApplicationsFrequently asked🔒 Read the full methodSourcesRelated methods
Cite this pageSpotted an issue on this page? Report or suggest a fix →
Home›Oncology Nursing›Memorial Symptom Assessment Scale (MSAS)
Process / pipelineComprehensive Multi-Symptom Assessment

Memorial Symptom Assessment Scale (MSAS)

Memorial Symptom Assessment Scale · Also known as: MSAS, MSAS-SF

The Memorial Symptom Assessment Scale is a comprehensive multisymptom instrument that captures both prevalence and distress of 32 cancer-related symptoms (full version) or 10 core symptoms (short form). Developed by Portenoy and colleagues at Memorial Sloan Kettering Cancer Center in 1994, the MSAS is designed for detailed symptom profiling in oncology research and clinical practice, enabling identification of symptom clusters and assessment of physical and psychological symptom burden separately.

ScholarGate
  1. Process / pipeline
  2. v1
  3. 2 Sources
  4. PUBLISHED
Cite this page →
Tools & resources
Download slides
Learn & explore

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Method map

The neighbourhood of related methods — select a node to explore.

MSAS
Brief Fatigue InventoryESASFACT-GFLICFACT-B

When to use it

MSAS (full or short form) is appropriate for detailed symptom assessment in oncology research and clinical contexts: Phase II/III clinical trials examining symptom toxicity and tolerability of novel therapies; observational studies of symptom prevalence, burden, and risk factors across cancer types; symptom-cluster analysis to identify distinct phenotypes and propose mechanistic interventions; palliative care and end-of-life settings for comprehensive symptom characterization; supportive care research evaluating interventions (exercise, psychosocial therapy, pharmacotherapy) for symptom improvement. Particularly useful when physical vs. psychological symptom separation is needed or when symptom distress (not just severity) is the primary outcome.

Strengths & limitations

Strengths
  • Comprehensive 32-symptom coverage (or 10-item short form); captures physical, psychological, and gastrointestinal symptom domains. Enables detailed symptom profiling and cluster analysis.
  • Dual assessment: prevalence (presence/absence) and distress (severity); distress focus better reflects clinical impact than presence alone. Physical and Psychological subscales enable domain-specific analysis.
  • Well-validated across cancer types, treatment phases, and languages (20+ translations). Robust internal consistency (Cronbach α ≥0.80 for subscales) and responsiveness to change.
  • MSAS-SF offers abbreviated 10-symptom version for busy clinical settings while preserving physical/psychological distinction and psychometric integrity.
  • Freely available for research and clinical use. Integrated into some cancer center symptom-monitoring systems.
Limitations
  • Full MSAS (32 items) is lengthier than ESAS (9 items); ~10–15 minutes completion time may exceed feasibility in high-volume clinic screening. MSAS-SF addresses this but loses some symptom granularity.
  • No single composite 'MSAS score' for easy database entry or longitudinal tracking; requires database infrastructure to track multiple subscales and GDI.
  • Individual symptom items brief and context-less; clinical follow-up conversations may be needed to clarify fatigue etiology, anxiety specificity, or symptom attributability.
  • Psychological subscale overlaps with formal psychiatric assessment; high anxiety/depression on MSAS does not diagnose mood disorder. Concurrent screening with PHQ-9, GAD-7, or psychiatric evaluation is recommended.
  • Symptom distress is subjective; patients' interpretations of 'distress' may vary. Standardized administration and clarification language help but do not eliminate variability.

Frequently asked

What is the difference between symptom severity and symptom distress on the MSAS?

Symptom severity (0–4: not at all to very severe) measures the intensity or objective magnitude of a symptom (e.g., pain intensity). Symptom distress measures the patient's subjective emotional response to that symptom (e.g., how much the pain bothers or worries them). A patient may rate severe fatigue (severity 4) but low distress (distress 1) if they are coping well; conversely, mild fatigue (severity 2) with high distress (distress 4) indicates profound emotional burden. Distress is the MSAS focus because it better predicts QoL and intervention need.

How do MSAS Physical and Psychological Subscales guide clinical intervention?

High Physical Subscale with low Psychological suggests symptom management targeting physical interventions (pain control, nutrition, fatigue management, antiemetics). High Psychological with lower Physical suggests psychosocial interventions (psychotherapy, anxiety medication, support groups, mindfulness). High on both indicates integrated approach combining physical symptom management with mental health support.

Should I use full MSAS or MSAS-SF in clinical practice?

Use MSAS-SF in routine clinical screening when time is limited (~5 min). Use full MSAS in research or when detailed symptom characterization is clinically important. MSAS-SF preserves Physical and Psychological subscales and Global Distress Index; full MSAS adds granularity for symptom-cluster analysis. No single universal recommendation; choose based on clinical context and available assessment time.

Can MSAS be used in non-cancer populations?

MSAS was developed and extensively validated in cancer populations. Use in non-cancer chronic illness (e.g., heart failure, COPD, HIV/AIDS) requires dedicated validation studies. The multisymptom, physical/psychological distinction model may be conceptually relevant, but normative data and responsiveness are cancer-specific. Consult published validation literature before adapting MSAS to non-cancer conditions.

Sources

  1. Portenoy, R. K., Thaler, H. T., Kornblith, A. B., et al. (1994). The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer, 30A(9), 1326–1336. DOI: 10.1016/0959-8049(94)90182-1 ↗
  2. Cook, K. F., Broemling, L. D., Johnson, R. L., et al. (2007). Development and preliminary psychometric evaluation of the MSAS-GI: a brief symptom assessment for patients with gastrointestinal cancer. J Pain Symptom Manage, 34(3), 280–289. link ↗

How to cite this page

ScholarGate. (2026, June 3). Memorial Symptom Assessment Scale. ScholarGate. https://scholargate.app/en/oncology-nursing/memorial-symptom-assessment-scale

Related methods

Brief Fatigue InventoryESASFACT-GFLIC

Which method?

Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.

  • Brief Fatigue InventoryOncology Nursing↔ compare
  • ESASOncology Nursing↔ compare
  • FACT-GOncology Nursing↔ compare
  • FLICOncology Nursing↔ compare
Compare side by side →

Referenced by

ESASFACT-BFLIC

Similar methods

ESASBrief Fatigue InventoryEORTC QLQ-C15-PALMcGill Quality of Life QuestionnaireMFIPiper Fatigue ScaleCancer Fatigue ScaleEORTC QLQ-C30

Related reference concepts

Psychosocial OncologyCancer Pain ManagementPalliative and End-of-Life CareSpecial Topics in Medical OncologyCancer Rehabilitation and Quality of LifeSymptom Management at End of Life

Spotted an issue on this page? Report or suggest a fix →

ScholarGate — MSAS (Memorial Symptom Assessment Scale). Retrieved 2026-07-21 from https://scholargate.app/en/oncology-nursing/memorial-symptom-assessment-scale · Dataset: https://doi.org/10.5281/zenodo.20539026
Quick facts
Originator
Russell Portenoy
Subfamily
Comprehensive Multi-Symptom Assessment
Year
1994
Type
Patient self-report multisymptom prevalence and distress scale
Related methods
Brief Fatigue InventoryESASFACT-GFLIC
ScholarGate

A content-first reference library for research methods — what each one is, how it works, and where it comes from.

Open data (CC-BY)

Explore

  • Library
  • Search the library…
  • Browse by field
  • Fields
  • Journey
  • Compare
  • Which method?

Reference

  • Subjects
  • Atlas
  • Glossary
  • Methodology
  • Philosophy

Your tools

  • Bookshelf
  • Desk
  • Chat

Company

  • About
  • Pricing
  • Contact
  • Suggest a method

Entries are compiled from published sources for reference. Verifying the accuracy and suitability of any information for your own use remains your responsibility.

© 2026 ScholarGate · A research-method reference library
  • Privacy
  • Cookies
  • Terms
  • Delete account